^
    BIOMARKER:

    TNFRSF8 positive

    i
    Other names: TNFRSF8, TNF Receptor Superfamily Member 8, Tumor Necrosis Factor Receptor Superfamily Member 8, Lymphocyte Activation Antigen CD30, CD30L Receptor, Ki-1 Antigen, D1S166E, CD30, Tumor Necrosis Factor Receptor Superfamily, Member 8, Cytokine Receptor CD30, CD30 Antigen, TNFRSF8, Ki-1
    Entrez ID:
    943
    Related biomarkers:
    Expression
    Others
    TNFRSF8 positive
    HL
    brentuximab vedotin
    Sensitive: A1 - Approval
    TNFRSF8 positive
    Cutaneous T-cell Lymphoma
    brentuximab vedotin
    Sensitive: A1 - Approval
    TNFRSF8 positive
    Diffuse Large B Cell Lymphoma
    brentuximab vedotin
    Sensitive: A2 - Guideline
    TNFRSF8 positive
    Peripheral T-cell Lymphoma
    brentuximab vedotin
    Sensitive: A2 - Guideline
    TNFRSF8 positive
    NHL
    TT11
    Sensitive: C2 – Inclusion Criteria
    TNFRSF8 positive
    Lymphoma
    AFM13
    Sensitive: C2 – Inclusion Criteria
    TNFRSF8 positive
    HL
    AFM13
    Sensitive: C2 – Inclusion Criteria
    TNFRSF8 positive
    HL
    TT11
    Sensitive: C3 – Early Trials
    TNFRSF8 positive
    Peripheral T-cell Lymphoma
    BV-ICE
    Sensitive: C3 – Early Trials
    TNFRSF8 positive
    Lymphoma
    T-lymphocyte cell therapy
    Sensitive: D – Preclinical